Siegfried AG
Industry
- Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
- Vaccines
Other Names/Subsidiaries
- Alliance Medical Products
- Hameln Pharmaceuticals
- Hameln RDS
- Penick
Latest on Siegfried AG
Catalent, Inc ’s big response to the COVID-19 pandemic proved its undoing, with the contract development and manufacturing organization’s eventual acquisition now pending by client Novo Nordisk A/S .
Catalent, Inc ’s big response to the COVID-19 pandemic proved its undoing, with the contract development and manufacturing organization’s eventual acquisition now pending by client Novo Nordisk A/S .
“Switzerland has four main sources of new biotech activity,” Swiss Biotech Association CEO Michael Altorfer told Scrip . “The first source is spin-offs from academic centres in the country, the secon
CNS specialist Neuraxpharm has appointed Philipp Pohoralek as the company’s new commercial central region officer and country manager for Germany from the start of September. He will focus on streng